berberine blood sugarberberine side effectsberberine vs metformin

Berberine vs. Metformin: What the Clinical Evidence Actually Shows

By Kasivit Editorial Team · May 27, 2026 · 22 min read

Kasivit Editorial Team

Evidence-based health research

May 2026 · 11 min read
🔬 Evidence-Based

📋 What This Article Covers

Both berberine and metformin activate the same core metabolic pathway — but they differ meaningfully in safety profile, available evidence, and who each is appropriate for. Here is what evidence actually shows.

How berberine and metformin both work (the AMPK mechanism explained)
What a small head-to-head pilot study found when the two were compared directly
Where berberine has a genuine clinical advantage — and where metformin does
Who each is appropriate for, and when combining them is dangerous
The right berberine dose, timing, and what to watch for

Few comparisons in integrative medicine attract more curiosity — and more misinformation — than berberine vs. metformin. Both are described as insulin sensitizers. Both are associated with weight loss. Both are promoted in metabolic health circles. And in recent years, berberine has acquired the popular shorthand "nature's metformin," a label that is both partially accurate and dangerously oversimplified.

The comparison is worth taking seriously because the underlying biochemistry is genuinely similar. But the clinical evidence, safety profiles, and appropriate patient populations are different in ways that matter. This article reviews all of it — without an agenda, and without the reflexive dismissal of either camp.

Background

What Is Berberine?

Berberine is a plant alkaloid — specifically an isoquinoline alkaloid — found in the roots, rhizomes, and bark of several plants including Berberis vulgaris (barberry), Hydrastis canadensis (goldenseal), Coptis chinensis (goldthread), and Phellodendron amurense. Its bright yellow color comes from the same chromophore responsible for its antimicrobial properties.

Traditional Chinese and Ayurvedic medicine have used berberine-containing plants for over 2,000 years, primarily for gastrointestinal infections. The mechanism behind its metabolic effects wasn't elucidated until 2004–2006, when researchers discovered that berberine activates AMP-activated protein kinase (AMPK) — the same enzyme targeted by metformin. That finding set off a wave of clinical investigation that has now generated dozens of randomized controlled trials.

Berberine is not FDA-approved as a drug. It is widely available as a dietary supplement in the United States. That distinction has real implications for the evidence base, regulatory oversight, and how physicians think about it — all of which we'll address.

Background

What Is Metformin?

Metformin is a biguanide — a class of compounds originally derived from guanidine, which occurs naturally in Galega officinalis (French lilac, or goat's rue). The drug was developed in the 1950s, introduced in the UK in 1957, and approved by the FDA in 1994. It has since become the most prescribed diabetes medication in the world, with an estimated 150 million active users globally.

Metformin's primary mechanisms include suppression of hepatic glucose production (via inhibition of mitochondrial complex I and activation of AMPK), increased glucose uptake in skeletal muscle, and modulation of the gut microbiome. It does not directly stimulate insulin secretion, and in the UKPDS metformin was associated with fewer hypoglycemic attacks than insulin or sulfonylureas¹ — a significant safety advantage.

Per American Diabetes Association guidelines, metformin remains first-line pharmacological therapy for type 2 diabetes unless contraindicated. Its evidence base includes the UK Prospective Diabetes Study (UKPDS), the Diabetes Prevention Program (DPP), and thousands of subsequent trials — an evidence record spanning nearly 70 years.

🔬 The Mechanism · Deep Dive

The AMPK Connection: Why They Work So Similarly

AMP-activated protein kinase (AMPK) is often called the "master metabolic switch." It functions as a cellular energy sensor: when the ratio of AMP to ATP rises — signaling low energy — AMPK is activated. Once activated, it initiates a cascade of effects that collectively improve metabolic function:

↑ Glucose uptake in skeletal muscle — AMPK stimulates translocation of GLUT4 transporters to the cell surface, independent of insulin.
↓ Hepatic glucose production — AMPK inhibits gluconeogenesis in the liver, reducing fasting blood glucose.
↑ Fatty acid oxidation — AMPK phosphorylates and inactivates ACC (acetyl-CoA carboxylase), reducing fat synthesis and increasing fat burning.
↑ Insulin sensitivity — downstream effects reduce systemic insulin resistance.

Metformin activates AMPK primarily by inhibiting mitochondrial complex I, which raises the cellular AMP/ATP ratio. Berberine also raises AMP/ATP by inhibiting complex I — but through a slightly different binding site. The result is the same activated downstream pathway, which is why their clinical effects overlap so substantially. This shared mechanism is not coincidence or marketing; it is documented biochemistry validated in multiple preclinical and clinical studies.

Clinical Evidence

Head-to-Head: What the Trials Actually Show

The most important direct comparison between berberine and metformin is a 2008 small pilot study published in Metabolism by Yin and colleagues.² It is a direct comparison, but it was small, so its results need confirming in larger trials.

📊

In a small pilot study, berberine's glucose-lowering effect was reported as similar to metformin's

In study A of this pilot, 36 adults with newly diagnosed type 2 diabetes were randomly assigned to berberine or metformin (0.5 g three times a day) for 3 months. In the berberine group, HbA1c fell from 9.5% to 7.5% and fasting blood glucose from 10.6 to 6.9 mmol/L, and the authors described berberine's glucose-lowering effect as similar to that of metformin. In study B, 48 adults with poorly controlled type 2 diabetes took berberine as an add-on to their existing treatment for 3 months (there was no metformin group), and total and LDL cholesterol fell. Across the pilot, 20 patients (34.5%) had temporary digestive side effects.²

Key finding: In a small pilot, glucose lowering with berberine was reported as similar to metformin; larger trials are needed to confirm this.

Yin J et al. Metabolism, 2008. 57(5):712–717. | Pilot study, 36 + 48 adults

📊

A 3-month placebo-controlled trial found berberine lowered blood sugar and lipids compared with placebo

Zhang and colleagues randomly assigned 116 people with type 2 diabetes and abnormal blood fats (dyslipidemia) to berberine (1.0 g a day) or placebo for 3 months. In the berberine group, fasting glucose fell from 7.0 to 5.6 mmol/L, HbA1c from 7.5% to 6.6%, triglycerides from 2.51 to 1.61 mmol/L and LDL cholesterol from 3.23 to 2.55 mmol/L, and these changes differed significantly from placebo. The only side effect reported was mild to moderate constipation in five participants taking berberine. This trial compared berberine with placebo, not with metformin.³

Key finding: Over 3 months, berberine improved both glucose and lipid measures compared with placebo.

Zhang Y et al. J Clin Endocrinol Metab, 2008. 93(7):2559–2565. | Placebo-controlled RCT, 116 patients, 3 months

📊

Meta-analysis of 27 trials: berberine did not differ significantly from oral glucose-lowering drugs, but study quality was limited

A 2015 meta-analysis of 27 randomized controlled trials (2,569 patients) found that berberine with lifestyle changes tended to lower fasting glucose, post-meal glucose and HbA1c more than lifestyle changes alone or placebo. When berberine was compared directly with oral glucose-lowering drugs, there was no statistically significant difference. No serious adverse reactions were reported in the included trials. The authors noted the overall limited quality of the studies and called for larger, better-designed trials.⁴

Key finding: Results point in the same direction across many small trials, but the evidence is of limited quality.

Lan J et al. J Ethnopharmacol, 2015. 161:69–81. | Meta-analysis, 27 RCTs

The honest read of this evidence: berberine has shown real glucose-lowering effects in trials, but the studies are mostly small and of limited quality. Pooled analyses of randomized trials find that berberine lowers HbA1c by about 0.6 percentage points on average compared with control.⁵ A meta-analysis comparing berberine with oral glucose-lowering drugs found no statistically significant difference,⁴ and another review rated the methodological quality of the trials as generally low.⁶ That is not the same as proof that the two are equivalent. The "nature's metformin" label reflects a shared mechanism and some short-term results. Where it breaks down is in the evidence categories that follow.

Advantages

Where Berberine Has a Distinct Edge

1. Possible Lipid Benefits

Berberine has lowered LDL cholesterol, total cholesterol and triglycerides in many trials, though results vary a lot between studies. In one meta-analysis of 41 trials, berberine-containing products lowered LDL cholesterol by about 15 mg/dL on average versus control, but products containing berberine alone did not lower LDL significantly (about 9 mg/dL, not statistically significant), and the trials differed widely from one another.⁷ In people with metabolic syndrome, a meta-analysis of placebo-controlled trials found lower triglycerides, fasting glucose and waist circumference with berberine.⁸ If you take a cholesterol medicine, talk to your prescriber or pharmacist before adding berberine.

2. Gut Microbiome Enrichment

Both agents alter the gut microbiome, but in different directions. Metformin produces complex and not entirely favorable shifts — including enrichment of Escherichia species that may contribute to its GI side effects. Berberine consistently enriches beneficial genera including Bifidobacterium and Lactobacillus, while reducing opportunistic species. For patients with GI concerns or those interested in microbiome health, this distinction matters.

3. Vitamin B12

Long-term metformin use is associated with lower vitamin B12 levels. In the Diabetes Prevention Program Outcomes Study, low or borderline-low B12 was more common after 13 years of metformin use (20.3% vs 15.6% with placebo), the risk of B12 deficiency rose with each year of metformin use, and nerve problems (neuropathy) were more common in metformin users who had low B12.⁹ Whether berberine affects vitamin B12 has not been studied, so it cannot be described as free of this effect. If you take metformin, ask your prescriber whether vitamin B12 testing is right for you.

4. Accessibility Without a Prescription

Berberine is available over the counter. For individuals in prediabetes, metabolic syndrome, or borderline insulin resistance who are not yet prescribed medications — and who may not have immediate access to healthcare — this matters practically. Some people who use GLP-1 medicines also take berberine, but we found no clinical studies of this combination, and berberine can add to blood-glucose lowering.¹⁰ Talk to your prescriber or pharmacist first. For more background, see our guide to supplements to consider with GLP-1 therapy.

Advantages

Where Metformin Has a Distinct Edge

1. Decades of Safety Data and Cardiovascular Outcomes Evidence

The UKPDS remains one of the most important diabetes trials ever conducted. In overweight patients with newly diagnosed type 2 diabetes, metformin reduced diabetes-related death by 42% and all-cause mortality by 36%¹, and in post-trial follow-up, risk reductions for heart attack (33%) and death from any cause (27%) were still present ten years later (the "legacy effect")¹¹. No supplement has this class of evidence. Berberine's long-term cardiovascular effects remain unstudied at this scale.

2. FDA Approval and Clinical Infrastructure

Metformin has defined dosing protocols, established contraindications (eGFR <30), known drug interactions, and decades of post-market surveillance. When you prescribe it, you can reference clinical guidelines, use calculators for renal adjustments, and rely on a robust pharmacovigilance system. Berberine has none of this infrastructure, because it has not been studied in the same populations at the same scale. Most berberine trials are short, and safety reporting in them is limited, so its long-term safety is not well defined.

3. Cost

Generic metformin costs under $10/month at most pharmacies. Quality berberine is typically $30–50/month. For long-term, daily use, this is not a trivial consideration for many patients.

Side-by-Side

Berberine vs. Metformin: A Direct Comparison

Parameter	Berberine	Metformin
Primary mechanism	AMPK activation (complex I inhibition)	AMPK activation (complex I inhibition)
HbA1c reduction	About 0.6 percentage points lower than control in pooled trials⁵; a larger fall in one small pilot with a high starting HbA1c²	Direct comparison data are limited
Fasting glucose	Significant reduction	Significant reduction
LDL cholesterol	Reduced in many trials; size of effect varies⁷	Minimal / neutral
Triglycerides	Significant reduction	Modest / variable
Vitamin B12	Not studied	Depletes with long-term use
GI side effects	Constipation and other digestive effects, usually mild or temporary in trials^2,3	Nausea, diarrhea (start low)
Cardiovascular outcomes data	No long-term RCT data	UKPDS: lower diabetes-related death and all-cause mortality¹
Gut microbiome	Enriches Bifidobacterium, Lactobacillus	Complex shifts; some GI disturbance
Drug interactions	Reduced CYP2D6, 2C9 and 3A4 activity in humans; raised cyclosporine levels^12,13	Few; avoid contrast dye/iodine
Requires prescription?	No	Yes (US)
Pregnancy	Avoid (limited safety data)	Used clinically (gestational DM)
Cost (monthly)	~$30–50 (supplement)	<$10 (generic)
Long-term safety data	Limited (years)	Extensive (decades)

Patient Selection

Who Is Each Option Best For?

🌿 Berberine

Consider Berberine If You…

Have prediabetes or borderline insulin resistance (not yet diagnosed T2D)
Have metabolic syndrome with elevated triglycerides or LDL
Prefer to discuss non-prescription options with a clinician first
Want a supplement that also supports gut microbiome health
Are working with a physician who supports integrative approaches

💊 Metformin

Metformin Is Indicated If You…

Have a confirmed type 2 diabetes diagnosis
Have elevated cardiovascular risk (UKPDS outcome benefit applies)
Are in an active clinical care relationship for diabetes management
Need a treatment with decades of pharmacovigilance and dosing guidance
Are pregnant or planning pregnancy (gestational DM)
Want the lowest possible monthly cost
Cannot reliably access quality supplements

Safety

Important Safety Considerations

⚠️

Do not combine berberine with metformin or any other diabetes medicine without talking to your prescriber. Both lower blood glucose, so their effects may add up, and low blood sugar is the main concern if you also take insulin or a sulfonylurea. A meta-analysis of trials of berberine alone or with oral glucose-lowering drugs did not find a significant increase in low blood sugar,⁵ but the combination has not been studied in depth, and a 2026 review lists additive blood-glucose lowering as a possible interaction.¹⁰ If you take metformin and are considering berberine, speak with your prescribing clinician first. Do not stop or change a prescribed medicine because of a supplement.

Berberine's Drug Interactions — Not to Be Ignored

Berberine can slow the liver and gut enzymes that break down many medicines. In healthy volunteers, two weeks of berberine (300 mg three times daily) reduced the activity of CYP2D6, CYP2C9 and CYP3A4.¹² In kidney-transplant recipients taking cyclosporine, berberine was associated with higher blood levels of the anti-rejection drug (trough concentration about 29% higher than in patients not taking berberine, and about 35% higher drug exposure in a small pharmacokinetic study).¹³ Many other commonly prescribed medicines are broken down by the same enzymes or moved by the same transporters, and for most of them the effect of berberine has not been tested in people. A 2026 review advises treating berberine as an active pharmacological agent rather than an inert supplement, especially alongside medicines with a narrow safety margin.¹⁰ Higher blood levels of an interacting medicine can cause more side effects, so ask your pharmacist or prescriber before combining.

This does not mean berberine cannot be used with any medication. It means berberine drug interactions require the same pharmacist-level review you'd give any prescription. If you are on multiple medications, check interactions before starting berberine. This is especially important for patients taking cyclosporine (transplant recipients) or certain cardiovascular drugs.

Heart Rhythm and Other Reported Concerns

In 2026, three case reports described life-threatening heart-rhythm problems (torsades de pointes, linked to a prolonged QT interval) in people taking berberine: a 61-year-old man who was also taking several other supplements and had low magnesium,¹⁴ a 36-year-old woman who had a cardiac arrest from this rhythm after several months of berberine use and whose symptoms and ECG changes resolved after she stopped it,¹⁵ and a 92-year-old man who developed this rhythm about two weeks after starting berberine.¹⁶ Only a small number of cases have been reported, and case reports cannot prove that berberine was the cause. A 2026 review also lists QT prolongation and blood-pressure lowering as possible additive effects of berberine.¹⁰ Tell your doctor that you take berberine if you have a heart-rhythm condition, take medicines that affect heart rhythm, or have low magnesium. Seek urgent medical care for fainting or a racing or irregular heartbeat.

Berberine and Pregnancy

Berberine should be avoided during pregnancy. The available evidence is mainly from laboratory and animal work: berberine displaced bilirubin from its carrier protein in the blood, and the author advised that berberine-rich herbs be avoided in jaundiced newborns and pregnant women.¹⁷ A later review found conflicting evidence on whether berberine causes neonatal jaundice and kernicterus (a form of brain damage from high bilirubin).¹⁸ Metformin, by contrast, is used in gestational diabetes, and a 2026 meta-analysis of 10 randomized trials concluded it appears safe and effective, although long-term outcomes in children remain uncertain.¹⁹ Decisions about diabetes treatment in pregnancy belong with the pregnant woman's own clinician.

Dosing for Blood Sugar Support

Berberine Doses Used in Trials

Dose

500 mg, 2–3 times per day (1,000–1,500 mg/day total) is the range used in several trials. The pilot study that compared berberine with metformin used 500 mg three times daily,² while other trials used different doses, for example 1,000 mg/day³ or 600 mg/day.²⁰ Check with your prescriber or pharmacist before starting, especially if you take any prescription medicine.

Timing

Take with meals. Taking doses with food, and splitting the daily dose across the day, is commonly advised.

Start Low

Begin at 500 mg once daily for 1–2 weeks before increasing, if your prescriber or pharmacist agrees that berberine is suitable for you. Starting low is commonly advised for digestive tolerance. Constipation and other digestive effects were the most commonly reported side effects in trials.^2,3,20

Duration

Most trials have run 3–6 months. Long-term safety data beyond 2 years is limited. Periodic reassessment with a physician is advisable for ongoing use.

From Kasivit

Kasivit Berberine: Formulated for Metabolic Support

💊 Product Spotlight · Kasivit

Kasivit Berberine for Healthy Metabolism

500 mg per capsule · 60 Vegan Capsules · Gluten-Free

Formulated at the 500 mg dose used in several clinical trials, including a small pilot study that compared berberine with metformin.² Each capsule delivers pure berberine HCl (berberine hydrochloride). Vegan, gluten-free, and free from unnecessary fillers. Take two to three capsules daily with meals (1,000–1,500 mg/day, the range used in several trials), and check with your prescriber or pharmacist first if you take any prescription medicine.

Shop Berberine → $39.90

Frequently Asked Questions

Berberine vs. Metformin: Common Questions Answered

Is berberine as effective as metformin for blood sugar?

In a small 3-month pilot study, berberine's glucose-lowering effect was reported as similar to metformin's.² Pooled analyses of randomized trials find that berberine lowers HbA1c by about 0.6 percentage points on average compared with control,⁵ and a meta-analysis found no statistically significant difference between berberine and oral glucose-lowering drugs, although study quality was limited.⁴ The evidence that berberine is equivalent to metformin is therefore limited. Metformin has a decades-long advantage in long-term safety data and cardiovascular outcomes evidence.

Can I take berberine instead of metformin?

If you have diagnosed type 2 diabetes, do not stop or replace metformin or any other prescribed diabetes medicine with berberine. Metformin is FDA-approved for T2D management and has demonstrated cardiovascular outcome benefits that berberine has not been studied for. For people with prediabetes or metabolic syndrome who are not prescribed medications, the evidence for berberine is encouraging but limited: one 12-week pilot trial in 34 people with prediabetes,²¹ and modest improvements in triglycerides, fasting glucose and waist size in metabolic syndrome.⁸ Discuss any supplement with your prescriber or pharmacist first.

Can I take berberine and metformin together?

Only after talking to your prescriber. Both lower blood glucose, so their effects may add up, and low blood sugar is the main concern if you also take insulin or a sulfonylurea. A meta-analysis did not find a significant increase in low blood sugar with berberine alone or with oral glucose-lowering drugs,⁵ but the combination has not been studied in depth.¹⁰ Do not start berberine alongside metformin on your own, and do not stop or change a prescribed medicine because of a supplement.

Why is berberine called "nature's metformin"?

Because both compounds activate AMPK — the "master metabolic switch" — through similar mechanisms (inhibition of mitochondrial complex I). The biochemical parallel is real and well-documented. Short-term results in small trials have been described as similar, but the quality of these trials is limited.^2,4,6 The label is partially accurate. Where it is misleading is the implied equivalence in safety data and long-term outcomes, where metformin has a far deeper evidence record.

Does berberine lower A1C?

On average, yes, modestly. Pooled analyses of randomized trials find that berberine lowers HbA1c by about 0.6 percentage points compared with control.⁵ One small 3-month pilot study reported a larger fall (9.5% to 7.5%) in adults with newly diagnosed diabetes and a high starting HbA1c, at 1,500 mg/day.² Study quality in this field is generally low, so the results are encouraging rather than settled.^4,6 Berberine is not a replacement for prescribed diabetes medicine.

What is the best dose of berberine for blood sugar?

There is no established best dose. Trials have used different doses: the pilot study that compared berberine with metformin used 500 mg three times a day with meals (1,500 mg/day),² and a placebo-controlled trial in type 2 diabetes used 1,000 mg/day.³ Higher doses have not been shown to work better, so do not exceed the dose on the product label. Starting with a low dose and increasing gradually is commonly advised. Check with your prescriber or pharmacist before starting.

Does berberine cause the same side effects as metformin?

Both mainly cause digestive effects. With berberine, constipation was the most commonly reported single side effect in the placebo-controlled trials,^3,20 and in one small pilot study 20 patients (34.5%) had temporary digestive effects.² Starting at a low dose and taking it with food is commonly advised. Trials have generally not reported serious side effects,^4,20 but in 2026 life-threatening heart-rhythm problems (torsades de pointes) were reported in a few people taking berberine supplements, some of whom were also taking other supplements or medicines.^14,15,16 Whether berberine affects vitamin B12 has not been studied, whereas long-term metformin use is associated with lower B12.⁹ Berberine's drug interaction profile via CYP enzyme inhibition also requires attention.¹²

Is berberine safe for the kidneys?

In the trials we reviewed, berberine did not change kidney or liver function tests,^2,13 but kidney safety has not been studied in depth, and a 2026 toxicology review of Berberis plants and their alkaloids reported toxicity affecting several organ systems, including the kidney and liver, under specific doses and conditions.²² By contrast, metformin requires dose reduction or discontinuation in patients with reduced kidney function (eGFR below 30 mL/min). However, berberine's safety in severe kidney disease has not been adequately studied. If you have CKD, discuss any metabolic supplement with your nephrologist before starting.

🔬 Evidence-Based Summary

A Supplement Worth Respecting — With Clear Limits

Berberine has shown real, if modest, glucose- and lipid-lowering effects in trials. The mechanism is reasonably well characterized. The head-to-head data with metformin come from one small pilot study, and reviews describe most berberine trials as small and of limited or low quality.^2,4,6 There is a growing body of clinical research on berberine, but it is not yet strong enough to treat berberine as an equal to metformin.

The appropriate limits are equally real. Berberine is not a replacement for metformin in diagnosed type 2 diabetes. The cardiovascular outcomes data that makes metformin the standard of care does not exist for berberine. The drug interaction profile via CYP enzymes requires careful review in people taking several medicines, and heart-rhythm problems have been reported in a few people taking berberine supplements.^14,15,16 And the long-term safety evidence is measured in years, not decades.

The most useful way to think about berberine: in people with metabolic syndrome, placebo-controlled trials show modest improvements in triglycerides, fasting glucose and waist size,⁸ while evidence in prediabetes is limited to a small pilot trial.²¹ For diagnosed type 2 diabetes management, berberine is a supplement to discuss with your prescriber, not a drug to replace. That distinction is not a dismissal. It is clinical precision.

Medical Disclaimer: This article is written for educational purposes and reflects a review of peer-reviewed literature. It is not medical advice and does not constitute a physician-patient relationship. Berberine is a dietary supplement, not an FDA-approved drug for any condition. If you have diabetes, prediabetes, a heart-rhythm condition, kidney or liver disease, are pregnant, or are taking prescription medications — including metformin, insulin, immunosuppressants such as cyclosporine, or any medication metabolized by CYP2D6, CYP2C9 or CYP3A4 — consult your healthcare provider before starting berberine. Do not stop or change prescription diabetes medicines because of a supplement.

References: (1) UKPDS Group. Lancet. 1998;352(9131):854-865. PubMed (PubMed lists no DOI for this record.) (2) Yin J, et al. Metabolism. 2008;57(5):712-717. PubMed · DOI (3) Zhang Y, et al. J Clin Endocrinol Metab. 2008;93(7):2559-2565. PubMed · DOI (4) Lan J, et al. J Ethnopharmacol. 2015;161:69-81. PubMed · DOI (5) Xie W, et al. Front Pharmacol. 2022;13:1015045. PubMed · DOI (6) Dong H, et al. Evid Based Complement Alternat Med. 2012;2012:591654. PubMed · DOI (7) Hernandez AV, et al. J Diet Suppl. 2024;21(2):242-259. PubMed · DOI (8) Liu D, et al. Front Pharmacol. 2025;16:1572197. PubMed · DOI (9) Aroda VR, et al. J Clin Endocrinol Metab. 2016;101(4):1754-1761. PubMed · DOI (10) Dumitru CN, et al. Pharmaceuticals (Basel). 2026;19(8):1313. PubMed · DOI (11) Holman RR, et al. N Engl J Med. 2008;359(15):1577-1589. PubMed · DOI (12) Guo Y, et al. Eur J Clin Pharmacol. 2012;68(2):213-217. PubMed · DOI (13) Wu X, et al. Eur J Clin Pharmacol. 2005;61(8):567-572. PubMed · DOI (14) Mohammadi A, et al. JACC Case Rep. 2026:110193 (online ahead of print). PubMed · DOI (15) Williams JM, et al. Cureus. 2026;18(6):e111276. PubMed · DOI (16) Mesmin MP, et al. Clin Pract Cases Emerg Med. 2026;10(3):392-394. PubMed · DOI (17) Chan E. Biol Neonate. 1993;63(4):201-208. PubMed · DOI (18) Linn YC, et al. Phytother Res. 2012;26(5):682-686. PubMed · DOI (19) Brinkmann MLS, et al. Diabet Med. 2026;43(2):e70173. PubMed · DOI (20) Chen YX, et al. Lancet Gastroenterol Hepatol. 2020;5(3):267-275. PubMed · DOI (21) Panigrahi A, et al. BMC Endocr Disord. 2023;23(1):190. PubMed · DOI (22) Ma J, et al. Phytomedicine. 2026;162:158782 (online ahead of print). PubMed · DOI

Kasivit Editorial Team

Wellness content curated by the Kasivit team. All supplement information is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement.